Metagenomi Therapeutics, Inc. (MGX)

Metagenomi Therapeutics Revenue

Metagenomi Therapeutics had revenue of $-257.00K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $13.56M, down -59.84% year-over-year. In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%. That makes Metagenomi Therapeutics the 35,903rd largest company in the world by revenue and 4,721st in the United States.

• Revenue (ttm): $13.56M
• Revenue Growth: -59.84%
• P/S Ratio: 2.24
• Revenue / Employee: $120,009
• Employees: 113
• Market Cap: 30.22M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	25.21M	-27.09M	-51.79%
Dec 31, 2024	52.30M	7.54M	16.84%
Dec 31, 2023	44.76M	27.56M	160.21%
Dec 31, 2022	17.20M	16.96M	6,978.19%
Dec 31, 2021	243.00K	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error